Dr. Linda M. Katz is the Director of the Office of Cosmetics and Colors (OCAC) and serves as the Senior Advisor, Cosmetics, to the Office of the Chief Scientist.  Dr. Katz joined FDA in 1989 in the Center for Drug Evaluation and Research (CDER) first as a primary medical officer and later as Team Leader and Acting Director of the Pilot Drug Evaluation Staff, which reviewed anti-rheumatic drugs, anesthetic agents, and drugs of abuse. Other positions in CDER included Deputy Director of the Division of Dermatologic and Dental Drug Products, and Deputy Director of the Division of Over-the-Counter Drug Products. In 2002, Dr. Katz joined the Center for Food Safety and Applied Nutrition (CFSAN), as the Director of OCAC and served over 10 years as the Acting Chief Medical Officer. Dr. Katz is responsible for establishing the strategic plans for OCAC and directing regulatory and research activities, and for liaising with industry, nongovernmental organizations, consumers, stakeholder groups, and national and international regulators on policy and research related issues. She is recognized nationally and internationally for cosmetic initiatives involving harmonization, safety, and legislative activities. Dr. Katz received her MD from the University of Connecticut School of Medicine, her MPH in Epidemiology from the University of Michigan School of Public Health, and her BA in Biology from the University of Pennsylvania. She did her residency in Internal Medicine and fellowship in Rheumatology at the George Washington Medical Center. Dr. Katz is an elected Fellow in the American College of Physicians and a Fellow in the American College of Rheumatology. In addition, Dr. Katz has taught at Walter Reed Army Medical Center and the Uniformed Services University of the Health Sciences and has numerous publications in the scientific and medical literature.